"Metastatic colon cancer" trang 1 - tải miễn phí từ tailieunhanh
Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects

Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects
9    42    1
Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: A retrospective study in mFOLFOX6 -treated patients

Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: A retrospective study in mFOLFOX6 -treated patients
8    34    1
Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression

Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression
17    52    1
Histopathological features predict metastatic potential in locally advanced colon carcinomas

Histopathological features predict metastatic potential in locally advanced colon carcinomas
14    25    1
Prospective study of oncologic outcomes after laparoscopic modified complete mesocolic excision for non-metastatic right colon cancer (PIONEER study): Study protocol of a multicentre single-arm trial

Prospective study of oncologic outcomes after laparoscopic modified complete mesocolic excision for non-metastatic right colon cancer (PIONEER study): Study protocol of a multicentre single-arm trial
10    84    1
Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer

Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer
10    54    1
Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients

Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients
9    61    2
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: A translational research study of the Hellenic Cooperative Oncology Group (HeCOG)

A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: A translational research study of the Hellenic Cooperative Oncology Group (HeCOG)
10    64    1
The survival impact of palliative chemotherapy dose modifications on metastatic colon cancer

The survival impact of palliative chemotherapy dose modifications on metastatic colon cancer
11    25    1
Malignant pericardial effusion as a primary manifestation of metastatic colon cancer: A case report

Malignant pericardial effusion as a primary manifestation of metastatic colon cancer: A case report
4    18    1
Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver

Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver
12    37    1
An integrated multi-omics approach to identify regulatory mechanisms in cancer metastatic processes

An integrated multi-omics approach to identify regulatory mechanisms in cancer metastatic processes
28    52    1
Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis

Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis
15    35    1
Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer

Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer
8    44    1
The lymph node status as a prognostic factor in colon cancer: Comparative population study of classifications using the logarithm of the ratio between metastatic and nonmetastatic nodes (LODDS) versus the pN-TNM classification and ganglion ratio systems

The lymph node status as a prognostic factor in colon cancer: Comparative population study of classifications using the logarithm of the ratio between metastatic and nonmetastatic nodes (LODDS) versus the pN-TNM classification and ganglion ratio systems
11    93    1
Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer

Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer
12    42    1